The distinctive nature of HER2-positive breast cancers
- PMID: 16236735
- DOI: 10.1056/NEJMp058197
The distinctive nature of HER2-positive breast cancers
Comment on
-
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.N Engl J Med. 2005 Oct 20;353(16):1659-72. doi: 10.1056/NEJMoa052306. N Engl J Med. 2005. PMID: 16236737 Clinical Trial.
-
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.N Engl J Med. 2005 Oct 20;353(16):1673-84. doi: 10.1056/NEJMoa052122. N Engl J Med. 2005. PMID: 16236738 Clinical Trial.
Similar articles
-
[ERBB2/HER2: from molecular to clinical oncology].Vopr Onkol. 2002;48(2):137-45. Vopr Onkol. 2002. PMID: 12227060 Review. Russian. No abstract available.
-
Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells.Int J Oncol. 2007 Oct;31(4):769-76. Int J Oncol. 2007. PMID: 17786307
-
HER2 status and benefit from adjuvant trastuzumab in breast cancer.N Engl J Med. 2008 Mar 27;358(13):1409-11. doi: 10.1056/NEJMc0801440. N Engl J Med. 2008. PMID: 18367751 No abstract available.
-
What is the ideal HER2 test for Herceptin therapy?Jpn J Clin Oncol. 2000 Apr;30(4):208-9, 211. Jpn J Clin Oncol. 2000. PMID: 10830993 No abstract available.
-
[Human recombinant anti-HER2 monoclonal antibody--a new targeted treatment in breast cancer].Orv Hetil. 2001 Nov 18;142(46):2563-8. Orv Hetil. 2001. PMID: 11770175 Review. Hungarian.
Cited by
-
Combined Docetaxel/Pictilisib-Loaded mPEGylated Nanocarriers with Dual HER2 Targeting Antibodies for Synergistic Chemotherapy of Breast Cancer.Int J Nanomedicine. 2022 Nov 17;17:5353-5374. doi: 10.2147/IJN.S388066. eCollection 2022. Int J Nanomedicine. 2022. PMID: 36419719 Free PMC article.
-
Multicenter Study Using Desorption-Electrospray-Ionization-Mass-Spectrometry Imaging for Breast-Cancer Diagnosis.Anal Chem. 2018 Oct 2;90(19):11324-11332. doi: 10.1021/acs.analchem.8b01961. Epub 2018 Sep 18. Anal Chem. 2018. PMID: 30170496 Free PMC article.
-
The Hierarchical Modular Structure of HER2+ Breast Cancer Network.Front Physiol. 2018 Oct 11;9:1423. doi: 10.3389/fphys.2018.01423. eCollection 2018. Front Physiol. 2018. PMID: 30364267 Free PMC article.
-
Current status and future perspectives in HER2 positive advanced gastric cancer.Clin Transl Oncol. 2022 Jun;24(6):981-996. doi: 10.1007/s12094-021-02760-0. Epub 2022 Jan 29. Clin Transl Oncol. 2022. PMID: 35091998 Review.
-
Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma.World J Gastroenterol. 2011 Mar 21;17(11):1501-6. doi: 10.3748/wjg.v17.i11.1501. World J Gastroenterol. 2011. PMID: 21472111 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous